Amantadine

Amantadine

SCHEMBL7395239

CSCCC(OC(=O)[C@H](C)CS)C(=O)O.NC12CC3CC(CC(C3)C1)C2

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BM

The experimentally established mechanism targets of Amantadine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
THRB P10828 1/20 0.35
CYP2C9 P11712 1/20 0.35
RNPEP Q9H4A4 1/20 0.33
FNTA P49354 1/20 0.31
FNTB P49356 1/20 0.31
PGGT1B P53609 1/20 0.31
ALOX15 P16050 1/20 0.31
ITGB1 P05556 1/20 0.30
ITGA4 P13612 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Amantadine SCHEMBL7395243 1.00 ALDH1A1 (0.40) ALDH1A1THRBCYP2C9RNPEPFNTA
Amantadine SCHEMBL7398905 0.90 THRB (0.34) ALDH1A1THRBCYP2C9ALOX15
Amantadine SCHEMBL7398902 0.90 THRB (0.34) ALDH1A1THRBCYP2C9ALOX15
Amantadine SCHEMBL7396579 0.90 THRB (0.37) ALDH1A1THRBCYP2C9ALOX15ITGB1
Amantadine SCHEMBL7396585 0.90 THRB (0.37) ALDH1A1THRBCYP2C9ALOX15ITGB1
SCHEMBL7399057 0.84 RNPEP (0.44) RNPEP
SCHEMBL7399053 0.84 RNPEP (0.44) RNPEP
Amantadine SCHEMBL7435558 0.83 THRB (0.38) ALDH1A1THRBCYP2C9ALOX15ITGB1
Amantadine SCHEMBL9298960 0.83 THRB (0.38) ALDH1A1THRBCYP2C9ALOX15ITGB1
Amantadine SCHEMBL7389642 0.83 THRB (0.35) ALDH1A1THRBCYP2C9ALOX15ITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0535042-B1 ANGIOTENSIS CONVERTING ENZYME INHIBITORS FISONS PLC (GB) 1995-03-29 EP disclosed
US-5348978-A Angiotensin converting enzyme inhibitors FISONS PLC (GB) 1994-09-20 US disclosed
EP-0535042-A1 ANGIOTENSIS CONVERTING ENZYME INHIBITORS. FISONS PLC (GB) 1993-04-07 EP disclosed
WO-1992000276-A2 ANGIOTENSIS CONVERTING ENZYME INHIBITORS FISONS PLC (GB) 1992-01-09 WO disclosed